CN102406762B

CN102406762B - Chinese medicinal preparation for treating chronic prostatitis

Info

Publication number: CN102406762B
Application number: CN2011103841397A
Authority: CN
Inventors: 殷常康
Original assignee: Individual
Current assignee: Individual
Priority date: 2011-11-18
Filing date: 2011-11-18
Publication date: 2013-02-20
Anticipated expiration: 2031-11-18
Also published as: CN102406762A

Abstract

The invention discloses a Chinese medicinal preparation for treating the chronic prostatitis. The traditional Chinese medical science considers that the chronic prostatitis has the main pathogenic factors of dampness and heat, extravasated blood and lier constraint and always has deficiency complicated with excess and sthenia. The traditional Chinese medicine has the treatment principles of clearing heat and removing turbidness and soothing the liver and removing blood stasis. Therefore, in the invention, astragalus, safflower, lumbricus, red paeony root, ligusticum wallichii, prunella vulgaris, kelp, indigowoad leaf and dandelion dahurian angelicaroot are selected to be prepared into decoction; after the decoction is orally administrated to a patient, a good treatment effect is obtained; by clinical tests, the total effective rate of the Chinese medicinal preparation reaches 91.1 percent and is obviously higher than that of the control group; and the Chinese medicinal preparation has no adverse effect and is valuable to be clinically popularized and applied.

Description

A kind of Chinese medicine preparation for the treatment of chronic prostatitis

Technical field

The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine preparation for the treatment of chronic prostatitis.

Background technology

Chronic prostatitis is commonly encountered diseases and the frequently-occurring disease of male genitourinary system, almost accounts for the first place of andrology's outpatient service.Because of primary disease treatment time longer, curative effect is lower, easily repeatedly and cause sexual dysfunction, patient often psychological burden is heavy, very easily increases the weight of the repeatedly outbreak of primary disease.Although modern age antibacterials development, because the barrier action of prostatic epithelium, antibiotic is difficult to bring into play direct therapeutical effect by prostate barrier penetration, therapeutic effect is not satisfactory.

At present, although the Chinese and western drugs for the treatment of chronic prostatitis is a lot, all exist therapeutic effect poor, side effect is large, the problem that relapse rate is high.

Summary of the invention

The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of chronic prostatitis.The traditional Chinese medical science thinks, damp and hot, congestion, stagnation of liver-QI then are the main pathological factors of primary disease, and mostly are the card of simulataneous insufficiency and excessive.For this reason, the traditional Chinese medical science should be turbid take the heat clearing away profit, the soothing liver-QI silt is as the Therapeutic Principle.

The objective of the invention is to be achieved through the following technical solutions, the Chinese medicine preparation of this treatment chronic prostatitis is made by the Chinese medicine of following weight portion: Radix Astragali 7-13 part, Flos Carthami 5-10 part, Pheretima 7-13 part, Radix Paeoniae Rubra 15-20 part, Rhizoma Chuanxiong 10-15 part, Spica Prunellae 5-9 part, Thallus Laminariae (Thallus Eckloniae) 7-13 part, Folium Isatidis 10-15 part, Herba Taraxaci 7-13 part, Radix Angelicae Dahuricae 5-10 part, Radix Bupleuri 10-15 part.

Preferably, the Chinese medicine preparation of this treatment chronic prostatitis is made by the Chinese medicine of following weight portion: 10 parts of the Radixs Astragali, 7 parts on Flos Carthami, 10 parts of Pheretimas, 17 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Chuanxiongs, 7 parts of Spica Prunellaes, 10 parts of Thallus Laminariae (Thallus Eckloniae)s, 12 parts of Folium Isatidiss, 10 parts of Herba Taraxacis, 7 parts of the Radixs Angelicae Dahuricae, 13 parts of Radix Bupleuri.

Making decoction according to traditional decocting method takes.

The Radix Astragali, Flos Carthami, Pheretima tonification vigour, removing blood stasis collateral dredging are monarch in the side, join Radix Paeoniae Rubra, Rhizoma Chuanxiong, Spica Prunellae, Thallus Laminariae (Thallus Eckloniae) with blood circulation promoting and blood stasis dispelling, hard masses softening and resolving; Folium Isatidis, Herba Taraxaci, the Radix Angelicae Dahuricae can heat-clearing and toxic substances removing, again can the dampness removing collateral dredging; Radix Bupleuri is evacuated and is brought down a fever the yang invigorating soothing liver-QI.All medicines share, and play altogether the merit of disperse blood stasis and dredge collateral, heat-clearing and toxic substances removing kidney tonifying.

Clinical data

1, physical data

It is to our hospital and make a definite diagnosis patients with chronic prostatitis that selected 112 examples are year February in August, 2006 to 2009.Be divided at random two groups.Treatment group 56 examples wherein, minimum 21 years old of age, maximum 64 years old, average 36 years old; The course of disease the shortest May, the longest 6 years, average 1.9 years.Matched group 56 examples, minimum 20 years old of age, maximum 63 years old, average 35.5 years old; The course of disease is the shortest 4.5 months, and is the longest 5.5 years, average 1.8 years.The physical data such as two groups of case sexes, age, the course of disease are learned by statistics and are processed there was no significant difference (P＞0.05), have comparability.

2, diagnostic criteria

Clinical symptoms: frequent micturition, dysurea, urinate smooth or burn feeling is arranged, dribble of urine not to the utmost, urinate eventually the end or when firmly defecating urethral orifice the white phenomenon of dripping is arranged, morning, the time-out urethral orifice had sticky discharge, lumbosacral region, perineal position, lower abdomen, groin, testis or spermatic cord, glans penis pain, sexual hypofunction or with sterile, or insomnia and dreamful sleep, stomachache, weak etc. are arranged.Digital rectal examination: the prostate normal in size, or slight increase, tenderness, surperficial soft or hard is inhomogeneous maybe can touch tuberosity.Prostatic fluid (EPS) checks: leukocyte＞10/HP, lecithin reduces.

3, Therapeutic Method

Treatment group is taken the Chinese medicine preparation of the chronic front adenitis for the treatment of of the present invention, namely get Radix Astragali 10g, Flos Carthami 7g, Pheretima 10g, Radix Paeoniae Rubra 17g, Rhizoma Chuanxiong 12g, Spica Prunellae 7g, Thallus Laminariae (Thallus Eckloniae) 10g, Folium Isatidis 12g, Herba Taraxaci 10g, Radix Angelicae Dahuricae 7g, Radix Bupleuri 13g, add water 500mL, steep first 20min, intense fire boils 30min, get liquid 200mL, every bu secondary is oral.

Matched group is taken QIANLIEKANG PIAN, 1 time 2,3 times on the 1st, oral.30 days is 1 course for the treatment of, period in a medicine other antagonism cooperative drug of stopping using.

4, criterion of therapeutical effect

The basic healing: subjective symptoms disappears, and the prostate glandular hyperplasia is stablized or dwindled, without frequent micturition, and urgent micturition, the soreness of waist, the prostatic fluid chemical examination is normal, and above indices was stablized more than 1 year; Effectively: cardinal symptom disappears or basic the disappearance, and prostatic hyperplasia is stablized constant, and without significantly frequent micturition, urgent micturition, and the normal or lecithin of examination of prostatic fluid increases more than 50%, and red, leukopenia is more than 50%, and continues 3 months; Invalid: after finishing the course for the treatment of, symptom is without obvious improvement, and prostate inflammatory hypertrophy is not improved.

5, therapeutic outcome

Two groups of curative effects compare: add up after treating a course for the treatment of, treatment group 56 examples are wherein cured 22 examples (39.3%), effective 29 examples (51.8%), and invalid 5 examples (8.90%), total effective rate is 91.1%; Matched group 56 examples are wherein cured 15 examples (26.8%), effective 28 examples (50.0%), and invalid 13 examples (23.2%), total effective rate is 76.8%.

Two groups of total effective rates relatively have significant difference (P＜0.01), illustrate that the curative effect for the treatment of group obviously is better than matched group.

Aspect clinical symptoms improved, wherein frequent micturition, urgent micturition, dysurea treatment group curative effect were better than matched group; Aspect elimination local symptom (perineal position discomfort/dull pain), treatment group also significantly is better than matched group; But improving stomachache, soreness of waist aspect, two groups of equal and good results compare there was no significant difference between group.

Untoward reaction does not all appear in two groups of clinical observations.

The specific embodiment

Embodiment one: take by weighing Radix Astragali 10g, Flos Carthami 7g, Pheretima 10g, Radix Paeoniae Rubra 17g, Rhizoma Chuanxiong 12g, Spica Prunellae 7g, Thallus Laminariae (Thallus Eckloniae) 10g, Folium Isatidis 12g, Herba Taraxaci 10g, Radix Angelicae Dahuricae 7g, Radix Bupleuri 13g, add water 500mL, steep first 20min, intense fire boils 30min, get liquid 200mL, every bu secondary is oral.

Embodiment two: take by weighing Radix Astragali 13g, Flos Carthami 5g, Pheretima 7g, Radix Paeoniae Rubra 15g, Rhizoma Chuanxiong 15g, Spica Prunellae 9g, Thallus Laminariae (Thallus Eckloniae) 7g, Folium Isatidis 15g, Herba Taraxaci 7g, Radix Angelicae Dahuricae 5g, Radix Bupleuri 15g, add water 500mL, steep first 20min, intense fire boils 30min, get liquid 200mL, every bu secondary is oral.

Embodiment three: take by weighing Radix Astragali 7g, Flos Carthami 10g, Pheretima 13g, Radix Paeoniae Rubra 20g, Rhizoma Chuanxiong 10g, Spica Prunellae 5g, Thallus Laminariae (Thallus Eckloniae) 13g, Folium Isatidis 10g, Herba Taraxaci 13g, Radix Angelicae Dahuricae 10g, Radix Bupleuri 10g, add water 500mL, steep first 20min, intense fire boils 30min, get liquid 200mL, every bu secondary is oral.

Claims

1. a Chinese medicine preparation for the treatment of chronic prostatitis is characterized in that the Chinese medicine preparation of this treatment chronic prostatitis is made by the Chinese medicine of following weight portion: Radix Astragali 7-13 part, Flos Carthami 5-10 part, Pheretima 7-13 part, Radix Paeoniae Rubra 15-20 part, Rhizoma Chuanxiong 10-15 part, Spica Prunellae 5-9 part, Thallus Laminariae (Thallus Eckloniae) 7-13 part, Folium Isatidis 10-15 part, Herba Taraxaci 7-13 part, Radix Angelicae Dahuricae 5-10 part, Radix Bupleuri 10-15 part.

2. a kind of Chinese medicine preparation for the treatment of chronic prostatitis according to claim 1 is characterized in that the Chinese medicine preparation of this treatment chronic prostatitis is made by the Chinese medicine of following weight portion: 10 parts of the Radixs Astragali, 7 parts on Flos Carthami, 10 parts of Pheretimas, 17 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Chuanxiongs, 7 parts of Spica Prunellaes, 10 parts of Thallus Laminariae (Thallus Eckloniae)s, 12 parts of Folium Isatidiss, 10 parts of Herba Taraxacis, 7 parts of the Radixs Angelicae Dahuricae, 13 parts of Radix Bupleuri.